These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3054319)

  • 21. Testing for drugs of abuse in meconium of newborn infants.
    Moriya F; Chan KM; Noguchi TT; Wu PY
    J Anal Toxicol; 1994; 18(1):41-5. PubMed ID: 8127083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug screening by enzyme immunoassay (EMIT) and thin-layer chromatography (Drug Skreen).
    Oellerich M; Külpmann WR; Haeckel R
    J Clin Chem Clin Biochem; 1977 May; 15(5):275-83. PubMed ID: 330794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of DRI enzyme immunoassays for drugs-of-abuse screening on the Cobas Mira.
    Broussard LA; Hanson L
    Clin Lab Sci; 1997; 10(2):83-6. PubMed ID: 10166356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drugs detected in patients suspected of acute intoxication.
    Baskin LB; Morgan DL
    Tex Med; 1997 Sep; 93(9):50-8. PubMed ID: 9754396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interference by nonsteroidal anti-inflammatory drugs in EMIT and TDx assays for drugs of abuse.
    Joseph R; Dickerson S; Willis R; Frankenfield D; Cone EJ; Smith DR
    J Anal Toxicol; 1995; 19(1):13-7. PubMed ID: 7723297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Triage screening for drugs of abuse in postmortem blood and urine samples.
    Moriya F; Hashimoto Y
    Nihon Hoigaku Zasshi; 1997 Jun; 51(3):214-9. PubMed ID: 9301227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of adulterating agents on FPIA analysis of urine for drugs of abuse.
    Schwarzhoff R; Cody JT
    J Anal Toxicol; 1993; 17(1):14-7. PubMed ID: 8429620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impairment in drivers due to cannabis in combination with other drugs.
    Gjerde H; Kinn G
    Forensic Sci Int; 1991; 50(1):57-60. PubMed ID: 1657744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and evaluation of immunochromatographic rapid tests for screening of cannabinoids, cocaine, and opiates in urine.
    Wennig R; Moeller MR; Haguenoer JM; Marocchi A; Zoppi F; Smith BL; de la Torre R; Carstensen CA; Goerlach-Graw A; Schaeffler J; Leinberger R
    J Anal Toxicol; 1998; 22(2):148-55. PubMed ID: 9547412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substance abuse testing of urine by GC/MS in scanning mode evaluated by proficiency studies, TLC/GC, and EMIT.
    Gibb RP; Cockerham H; Goldfogel GA; Lawson GM; Raisys VA
    J Forensic Sci; 1993 Jan; 38(1):124-33. PubMed ID: 8381160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study.
    Schwettmann L; Külpmann WR; Vidal C
    Clin Chem Lab Med; 2006; 44(4):479-87. PubMed ID: 16599844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening of blood and urine for drugs of abuse utilizing diagnostic products corporation's Coat-A-Count radioimmunoassay kits.
    Appel TA; Wade NA
    J Anal Toxicol; 1989; 13(5):274-6. PubMed ID: 2515393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct detection of therapeutic concentrations of tricyclic antidepressants in whole hemolyzed blood using the EMITtox serum tricyclic antidepressant assay.
    Asselin WM; Leslie JM
    J Anal Toxicol; 1991; 15(4):167-73. PubMed ID: 1943065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Psychoactive substances in biological samples--toxicological laboratory data].
    Gomółka E; Wilimowska J; Piekoszewski W; Groszek B
    Przegl Lek; 2004; 61(4):323-7. PubMed ID: 15521594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of drugs of abuse in less than 30-year-old drivers killed in a road crash in France: a spectacular increase for cannabis, cocaine and amphetamines.
    Mura P; Chatelain C; Dumestre V; Gaulier JM; Ghysel MH; Lacroix C; Kergueris MF; Lhermitte M; Moulsma M; Pépin G; Vincent F; Kintz P
    Forensic Sci Int; 2006 Jul; 160(2-3):168-72. PubMed ID: 16229982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A one-step extraction procedure for the screening of cocaine, amphetamines and cannabinoids in postmortem blood samples.
    Pelição FS; Peres MD; Pissinate JF; De Martinis BS
    J Anal Toxicol; 2014; 38(6):341-8. PubMed ID: 24782143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct determination of benzoylecgonine in serum by EMIT d.a.u. cocaine metabolite immunoassay.
    Poklis A; Jortani S; Edinboro LE; Saady JJ
    J Anal Toxicol; 1994; 18(7):419-22. PubMed ID: 7861757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of hair analyses for drugs of abuse and comparison with self-reports and urine tests.
    Musshoff F; Driever F; Lachenmeier K; Lachenmeier DW; Banger M; Madea B
    Forensic Sci Int; 2006 Jan; 156(2-3):118-23. PubMed ID: 16410161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.